.Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P01B_Antimalarials.P01BF03_ArtesunateAndAmodiaquine.ArtesunateAndAmodiaquine .Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P01B_Antimalarials.P01BF03_ArtesunateAndAmodiaquine.ArtesunateAndAmodiaquine| name: | ArtesunateAndAmodiaquine |
| ATC code: | P01BF03 | route: | oral |
| n-compartments | 1 |
Artesunate and amodiaquine is a fixed-dose combination antimalarial drug, used primarily for the treatment of uncomplicated Plasmodium falciparum malaria. Artesunate is a fast-acting artemisinin derivative, while amodiaquine is a 4-aminoquinoline antimalarial. The combination is recommended by the WHO and is widely used and approved for first-line malaria treatment in endemic regions.
Pharmacokinetic parameters reported for healthy African adults (both genders), median age 24 years, following administration of oral fixed-dose artesunate-amodiaquine (200 mg artesunate + 540 mg amodiaquine) once daily for 3 days.